Skip to main content
NCBI home page
The Yale Journal of Biology and Medicine logoLink to The Yale Journal of Biology and Medicine
. 1990 Sep-Oct;63(5):477–486.

The major histocompatibility complex: the value of extended haplotypes in the analysis of associated immune diseases and disorders.

M S Kruskall 1
PMCID: PMC2589374  PMID: 2293506

Abstract

Major histocompatibility complex antigens are critical to an animal's immune response. In most animals, the extreme polymorphism of MHC molecules complicates studies of the role of this complex in the immune response. In mice, however, MHC haplotype-homozygous inbred strains have been developed which are invaluable in the study of the immune system and the search for immune response genes. The human MHC bears many similarities to its murine equivalent with regard to antigen structure and polymorphism; furthermore, a number of combinations of specific MHC alleles between HLA-B and HLA-DR/DQ (extended haplotypes) are found in people more commonly than predicted by individual allele frequencies. Over 30 percent of Caucasian haplotypes are extended haplotypes, and over 55 percent of individuals have at least one extended haplotype. Examples of the same extended haplotype, even in unrelated individuals, should either all have or lack any gene within the MHC region. The value of considering extended haplotypes in searching for associations between the MHC and diseases, or immune response, is shown in three examples: congenital adrenal hyperplasia, hepatitis B immunization, and transfusion-associated graft-versus-host disease.

Full text

PDF
477

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alper C. A., Fleischnick E., Awdeh Z., Katz A. J., Yunis E. J. Extended major histocompatibility complex haplotypes in patients with gluten-sensitive enteropathy. J Clin Invest. 1987 Jan;79(1):251–256. doi: 10.1172/JCI112791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Alper C. A., Fleischnick E., Awdeh Z., Raum D., Crigler J. F., Jr, Gerald P. S., Yunis E. J. Extended MHC haplotypes in salt-losing 21-hydroxylase deficiency. Ann N Y Acad Sci. 1985;458:28–35. doi: 10.1111/j.1749-6632.1985.tb14586.x. [DOI] [PubMed] [Google Scholar]
  3. Alper C. A., Kruskall M. S., Marcus-Bagley D., Craven D. E., Katz A. J., Brink S. J., Dienstag J. L., Awdeh Z., Yunis E. J. Genetic prediction of nonresponse to hepatitis B vaccine. N Engl J Med. 1989 Sep 14;321(11):708–712. doi: 10.1056/NEJM198909143211103. [DOI] [PubMed] [Google Scholar]
  4. Awdeh Z. L., Alper C. A., Eynon E., Alosco S. M., Stein R., Yunis E. J. Unrelated individuals matched for MHC extended haplotypes and HLA-identical siblings show comparable responses in mixed lymphocyte culture. Lancet. 1985 Oct 19;2(8460):853–856. doi: 10.1016/s0140-6736(85)90123-0. [DOI] [PubMed] [Google Scholar]
  5. Awdeh Z. L., Raum D., Yunis E. J., Alper C. A. Extended HLA/complement allele haplotypes: evidence for T/t-like complex in man. Proc Natl Acad Sci U S A. 1983 Jan;80(1):259–263. doi: 10.1073/pnas.80.1.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bell J. I., Denny D. W., Jr, McDevitt H. O. Structure and polymorphism of murine and human class II major histocompatibility antigens. Immunol Rev. 1985 Jul;84:51–71. doi: 10.1111/j.1600-065x.1985.tb01125.x. [DOI] [PubMed] [Google Scholar]
  7. Benacerraf B., McDevitt H. O. Histocompatibility-linked immune response genes. Science. 1972 Jan 21;175(4019):273–279. doi: 10.1126/science.175.4019.273. [DOI] [PubMed] [Google Scholar]
  8. Bjorkman P. J., Saper M. A., Samraoui B., Bennett W. S., Strominger J. L., Wiley D. C. Structure of the human class I histocompatibility antigen, HLA-A2. Nature. 1987 Oct 8;329(6139):506–512. doi: 10.1038/329506a0. [DOI] [PubMed] [Google Scholar]
  9. Buus S., Sette A., Colon S. M., Miles C., Grey H. M. The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides. Science. 1987 Mar 13;235(4794):1353–1358. doi: 10.1126/science.2435001. [DOI] [PubMed] [Google Scholar]
  10. Choo S. Y., Antonelli P., Nisperos B., Nepom G. T., Hansen J. A. Six variants of HLA-B27 identified by isoelectric focusing. Immunogenetics. 1986;23(1):24–29. doi: 10.1007/BF00376518. [DOI] [PubMed] [Google Scholar]
  11. Dienstag J. L., Werner B. G., Polk B. F., Snydman D. R., Craven D. E., Platt R., Crumpacker C. S., Ouellet-Hellstrom R., Grady G. F. Hepatitis B vaccine in health care personnel: safety, immunogenicity, and indicators of efficacy. Ann Intern Med. 1984 Jul;101(1):34–40. doi: 10.7326/0003-4819-101-1-34. [DOI] [PubMed] [Google Scholar]
  12. Dunham I., Sargent C. A., Trowsdale J., Campbell R. D. Molecular mapping of the human major histocompatibility complex by pulsed-field gel electrophoresis. Proc Natl Acad Sci U S A. 1987 Oct;84(20):7237–7241. doi: 10.1073/pnas.84.20.7237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Flavell R. A., Allen H., Huber B., Wake C., Widera G. Organization and expression of the MHC of the C57 black/10 mouse. Immunol Rev. 1985 Jul;84:29–50. doi: 10.1111/j.1600-065x.1985.tb01124.x. [DOI] [PubMed] [Google Scholar]
  14. Fleischnick E., Awdeh Z. L., Raum D., Granados J., Alosco S. M., Crigler J. F., Jr, Gerald P. S., Giles C. M., Yunis E. J., Alper C. A. Extended MHC haplotypes in 21-hydroxylase-deficiency congenital adrenal hyperplasia: shared genotypes in unrelated patients. Lancet. 1983 Jan 22;1(8317):152–156. doi: 10.1016/s0140-6736(83)92757-5. [DOI] [PubMed] [Google Scholar]
  15. Gotch F. M., Kelly C., Ellis S. A., Wallace L., Rickinson A. B., van der Poel J., Crumpton M. J., McMichael A. J. Characterization of the HLA-A2.2 subtype: T cell evidence for further heterogeneity. Immunogenetics. 1985;21(1):11–23. doi: 10.1007/BF00372237. [DOI] [PubMed] [Google Scholar]
  16. Jilg W., Schmidt M., Deinhardt F. Four-year experience with a recombinant hepatitis B vaccine. Infection. 1989 Mar-Apr;17(2):70–76. doi: 10.1007/BF01646879. [DOI] [PubMed] [Google Scholar]
  17. Juji T., Takahashi K., Shibata Y., Ide H., Sakakibara T., Ino T., Mori S. Post-transfusion graft-versus-host disease in immunocompetent patients after cardiac surgery in Japan. N Engl J Med. 1989 Jul 6;321(1):56–56. doi: 10.1056/NEJM198907063210116. [DOI] [PubMed] [Google Scholar]
  18. Krensky A. M., Weiss A., Crabtree G., Davis M. M., Parham P. T-lymphocyte-antigen interactions in transplant rejection. N Engl J Med. 1990 Feb 22;322(8):510–517. doi: 10.1056/NEJM199002223220805. [DOI] [PubMed] [Google Scholar]
  19. Kruskall M. S., Eynon E. E., Awdeh Z., Alper C. A., Yunis E. J. Identification of HLA-B44 subtypes associated with extended MHC haplotypes. Immunogenetics. 1987;26(4-5):216–219. doi: 10.1007/BF00346515. [DOI] [PubMed] [Google Scholar]
  20. Laron Z., Pollack M. S., Zamir R., Roitman A., Dickerman Z., Levine L. S., Lorenzen F., O'Neill G. J., Pang S., New M. I. Late onset 21-hydroxylase deficiency and HLA in the Ashkenazi population: a new allele at the 21-hydroxylase locus. Hum Immunol. 1980 Jul;1(1):55–66. doi: 10.1016/0198-8859(80)90009-9. [DOI] [PubMed] [Google Scholar]
  21. McDevitt H. O., Chinitz A. Genetic control of the antibody response: relationship between immune response and histocompatibility (H-2) type. Science. 1969 Mar 14;163(3872):1207–1208. doi: 10.1126/science.163.3872.1207. [DOI] [PubMed] [Google Scholar]
  22. Milich D. R., Chisari F. V. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). I. H-2 restriction of the murine humoral immune response to the a and d determinants of HBsAg. J Immunol. 1982 Jul;129(1):320–325. [PubMed] [Google Scholar]
  23. O'Brien S. J., Roelke M. E., Marker L., Newman A., Winkler C. A., Meltzer D., Colly L., Evermann J. F., Bush M., Wildt D. E. Genetic basis for species vulnerability in the cheetah. Science. 1985 Mar 22;227(4693):1428–1434. doi: 10.1126/science.2983425. [DOI] [PubMed] [Google Scholar]
  24. Otsuka S., Kunieda K., Hirose M., Takeuchi H., Mizutani Y., Nagaya M., Sato G., Kasuya S., Matsutomo K., Noma A. Fatal erythroderma (suspected graft-versus-host disease) after cholecystectomy. Retrospective analysis. Transfusion. 1989 Jul-Aug;29(6):544–548. doi: 10.1046/j.1537-2995.1989.29689318456.x. [DOI] [PubMed] [Google Scholar]
  25. Parkman R., Mosier D., Umansky I., Cochran W., Carpenter C. B., Rosen F. S. Graft-versus-host disease after intrauterine and exchange transfusions for hemolytic disease of the newborn. N Engl J Med. 1974 Feb 14;290(7):359–363. doi: 10.1056/NEJM197402142900703. [DOI] [PubMed] [Google Scholar]
  26. Pollack M. S., Levine L., Zachmann M., Prader A., New M., Oberfield S., Dupont B. Possible genetic linkage disequilibrium between HLA and the 21-hydroxylase deficiency gene (congenital adrenal hyperplasia). Transplant Proc. 1979 Jun;11(2):1315–1316. [PubMed] [Google Scholar]
  27. Raum D., Awdeh Z., Yunis E. J., Alper C. A., Gabbay K. H. Extended major histocompatibility complex haplotypes in type I diabetes mellitus. J Clin Invest. 1984 Aug;74(2):449–454. doi: 10.1172/JCI111441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Sakakibara T., Juji T. Post-transfusion graft-versus-host disease after open heart surgery. Lancet. 1986 Nov 8;2(8515):1099–1099. doi: 10.1016/s0140-6736(86)90496-4. [DOI] [PubMed] [Google Scholar]
  29. Stutman O., Yunis E. J., Teague P. O., Good R. A. Graft-versus-host reactions induced by transplantation of parental strain thymus in neonatally thymectomized F1 hybrid mice. Transplantation. 1968 Jul;6(4):514–523. doi: 10.1097/00007890-196807000-00002. [DOI] [PubMed] [Google Scholar]
  30. Thaler M., Shamiss A., Orgad S., Huszar M., Nussinovitch N., Meisel S., Gazit E., Lavee J., Smolinsky A. The role of blood from HLA-homozygous donors in fatal transfusion-associated graft-versus-host disease after open-heart surgery. N Engl J Med. 1989 Jul 6;321(1):25–28. doi: 10.1056/NEJM198907063210105. [DOI] [PubMed] [Google Scholar]
  31. Vasilov R. G., Hahn A., Mölders H., van Rood J. J., Breuning M., Ploegh H. L. Analysis of human class I antigens by two-dimensional gel electrophoresis. I. Polymorphism, evidence for additional (non-HLA-A, B, C) gene products, and identification of variant HLA-A, B antigens. Immunogenetics. 1983;17(4):333–356. doi: 10.1007/BF00372454. [DOI] [PubMed] [Google Scholar]
  32. Wainwright R. B., McMahon B. J., Bulkow L. R., Hall D. B., Fitzgerald M. A., Harpster A. P., Hadler S. C., Lanier A. P., Heyward W. L. Duration of immunogenicity and efficacy of hepatitis B vaccine in a Yupik Eskimo population. JAMA. 1989 Apr 28;261(16):2362–2366. [PubMed] [Google Scholar]
  33. Weiden P. L., Zuckerman N., Hansen J. A., Sale G. E., Remlinger K., Beck T. M., Buckner C. D. Fatal graft-versus-host disease in a patient with lymphoblastic leukemia following normal granulocyte transfusion. Blood. 1981 Feb;57(2):328–332. [PubMed] [Google Scholar]
  34. White P. C., New M. I., Dupont B. Congenital adrenal hyperplasia (2). N Engl J Med. 1987 Jun 18;316(25):1580–1586. doi: 10.1056/NEJM198706183162506. [DOI] [PubMed] [Google Scholar]
  35. White P. C., New M. I., Dupont B. Congenital adrenal hyperplasia. (1). N Engl J Med. 1987 Jun 11;316(24):1519–1524. doi: 10.1056/NEJM198706113162406. [DOI] [PubMed] [Google Scholar]

Articles from The Yale Journal of Biology and Medicine are provided here courtesy of Yale Journal of Biology and Medicine

RESOURCES